Take a look at our year as told by the numbers to see a snapshot of the breakthrough scientific discoveries and important work happening at CCR.
- 393 Open Clinical Trials
- 29 New Clinical Trials
- 1,686 New Patients
- 244 Principal Investigators
- 9 New Faculty Recruits*
- 5 Newly Tenured Investigators*
- 296/87 Staff Scientists/Staff Clinicians
- ~600 Technical Lab Staff
- 832/115 Postdoctoral/Clinical Fellows
- 375/75 Postbaccalaureate/Predoctoral Students
- 207 Summer Students
- >1,100 Articles in Peer-Reviewed Journals
- 64 Technology Facilities and Platforms
Technology Transfer Activities
- 85 New Employee Invention Reports
- 27 Issued U.S. Patents
- 31 New Cooperative Research and Development Agreements (CRADAs)
- 187 Active CRADAs
- 92 Clinical CRADAs
- 7 Umbrella CRADAs
- 10 New Clinical Trial Agreements (CTAs)
- 114 Active CTAs
- 125 New Licenses for CCR Technologies
- 675 Active Licenses
- 1 FDA Approval
- 1 FDA Orphan Drug Designation*
- 1 FDA Breakthrough Therapy Designation
The NCI Technology Transfer Center (TTC) works to enable and guide collaboration, invention development and licensing to advance today’s discoveries into tomorrow’s medical care. The TTC supports technology development activities for NCI in therapeutics, diagnostics, research tools, vaccines, devices and software and facilitates partnerships with outside organizations so that NCI discoveries can reach the public in a timely manner.
For information on licensing and co-development opportunities, contact the TTC Invention Development and Marketing Unit (ncitechtransfer@mail.nih.gov).
Numbers are for fiscal year 2023 unless otherwise marked.
*Numbers are for calendar year 2023.